By Daniel R. Matlis, President
“Necessity is the mother of invention,” says the ancient proverb. In my opinion, the corollary is: “disruption is the matriarch of transformation,” especially for the Life-Sciences industries.
The COVID-19 epidemic has been the biggest global disruption in our generation. It represents a watershed moment for transformation throughout our industry.
Disruption is the new normal. This new paradigm is forcing Life-Science companies to re-imagine the way they operate; transforming and accelerating product development, regulatory review, manufacturing, and distribution cycles aimed at improving patient outcomes.Continue reading